Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment . (2014). Brazilian Journal of Pharmaceutical Sciences, 50(2), 345-352. https://doi.org/10.1590/S1984-82502014000200014